StockData
BioAge Labs, Inc. logo

BioAge Labs, Inc. (BIOA) income statement

BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$4.28−0.43 (-9.13%)

Close on Nov 20, 2026Market cap $196.44MP/E –Yield –

See a number that looks wrong?